(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-2.67% $ 2.55
Live Chart Being Loaded With Signals
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally...
Stats | |
---|---|
Объем за сегодня | 642.00 |
Средний объем | 8 930.00 |
Рыночная капитализация | 14.80M |
EPS | $0 ( 2024-03-21 ) |
Дата следующего отчета о доходах | ( $0 ) 2024-05-07 |
Last Dividend | $0.0700 ( 2023-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Mehalik Daniella | Buy | 70 000 | Stock Option (Right to Buy) |
2024-01-22 | Mehalik Daniella | Buy | 35 000 | Stock Option (Right to Buy) |
2023-11-27 | Mehalik Daniella | Sell | 0 | Common Stock, $.005 Par Value |
2023-09-21 | Shoemaker Shannon | Buy | 80 000 | Stock Option (Right to Buy) |
2023-09-21 | Shoemaker Shannon | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
94.07 |
Last 96 transactions |
Buy: 1 000 549 | Sell: 33 710 |
Psychemedics Corp Корреляция
10 Самые положительные корреляции | |
---|---|
HALL | 0.894 |
GSM | 0.876 |
ALTA | 0.873 |
NEXI | 0.862 |
OSMT | 0.861 |
MRUS | 0.86 |
XPER | 0.855 |
SNCR | 0.848 |
PAYO | 0.847 |
SRZN | 0.844 |
10 Самые отрицательные корреляции | |
---|---|
CLDX | -0.902 |
BNIXU | -0.901 |
BLZE | -0.881 |
NUTX | -0.878 |
RDVT | -0.872 |
GLMD | -0.844 |
STIM | -0.843 |
BGNE | -0.843 |
COFS | -0.842 |
HALO | -0.842 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Psychemedics Corp Финансовые показатели
Annual | 2023 |
Выручка: | $22.10M |
Валовая прибыль: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2023 |
Выручка: | $22.10M |
Валовая прибыль: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2022 |
Выручка: | $25.24M |
Валовая прибыль: | $9.29M (36.81 %) |
EPS: | $-0.190 |
FY | 2021 |
Выручка: | $24.91M |
Валовая прибыль: | $10.26M (41.21 %) |
EPS: | $-0.119 |
Financial Reports:
No articles found.
Psychemedics Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0800 | 1997-01-13 |
Last Dividend | $0.0700 | 2023-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-08 | |
Next Payout Date | N/A | |
# dividends | 100 | -- |
Total Paid Out | $12.60 | -- |
Avg. Dividend % Per Year | 1.61% | -- |
Score | 2.88 | -- |
Div. Sustainability Score | 2.34 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.792 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.400 | 1.67% |
1998 | $0.440 | 1.87% |
1999 | $0.640 | 3.20% |
2000 | $0.640 | 3.56% |
2001 | $0.400 | 2.00% |
2002 | $0.240 | 1.46% |
2003 | $0.320 | 3.43% |
2004 | $0.320 | 3.37% |
2005 | $0.360 | 2.82% |
2006 | $0.475 | 3.39% |
2007 | $0.575 | 2.99% |
2008 | $0.660 | 4.13% |
2009 | $0.580 | 9.01% |
2010 | $0.480 | 6.08% |
2011 | $0.480 | 5.66% |
2012 | $0.600 | 6.49% |
2013 | $0.600 | 5.52% |
2014 | $0.600 | 4.14% |
2015 | $0.600 | 3.98% |
2016 | $0.600 | 6.17% |
2017 | $0.600 | 2.50% |
2018 | $0.690 | 3.33% |
2019 | $0.720 | 4.46% |
2020 | $0.180 | 2.00% |
2021 | $0.0500 | 0.97% |
2022 | $0.210 | 2.94% |
2023 | $0.140 | 2.84% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.188 | 1.500 | -3.76 | -5.64 | [0 - 0.5] |
returnOnAssetsTTM | -0.313 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.498 | 1.500 | -6.64 | -9.96 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.445 | 0.800 | 7.77 | 6.22 | [1 - 3] |
quickRatioTTM | 1.204 | 0.800 | 7.62 | 6.10 | [0.8 - 2.5] |
cashRatioTTM | 0.417 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.173 | -1.500 | 7.11 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 4.22 | 1.000 | 9.55 | 9.55 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.138 | -0.277 | [0 - 20] |
debtEquityRatioTTM | 0.344 | -1.500 | 8.62 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.381 | 1.000 | 6.99 | 6.99 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.132 | 1.000 | -4.64 | -4.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.644 | 1.000 | -4.69 | -4.69 | [0.2 - 2] |
assetTurnoverTTM | 1.665 | 0.800 | 2.23 | 1.785 | [0.5 - 2] |
Total Score | 2.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.56 | 1.000 | -0.461 | 0 | [1 - 100] |
returnOnEquityTTM | -0.498 | 2.50 | -4.27 | -9.96 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.0923 | -0.277 | [0 - 30] |
dividendYielPercentageTTM | 2.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.239 | 1.500 | -1.741 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0670 | 1.000 | -4.17 | 0 | [0.1 - 0.5] |
Total Score | -0.760 |
Psychemedics Corp
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа